Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease

Julio A. Chirinos, Juan P. Zambrano, Simon Chakko, Anila Veerani, Alan Schob, Howard J. Willens, Guido Perez, Armando J Mendez

Research output: Contribution to journalArticle

255 Citations (Scopus)

Abstract

Pulse pressure (PP), a marker of arterial stiffness, predicts cardiovascular risk. We aimed to determine whether augmentation pressure (AP) derived from the aortic pressure waveform predicts major adverse cardiovascular events (MACE) and death independently of PP in patients with established coronary artery disease (CAD). We prospectively followed-up 297 males undergoing coronary angiography for 1186 ± 424 days. Ascending aortic pressure tracings obtained during catheterization were used to calculate AP (difference between the second and the first systolic peak). Augmentation index (AIx) was defined as AP as a percentage of PP. We evaluated whether AP and AIx can predict the risk of MACE (unstable angina, acute myocardial infarction, coronary revascularization, stroke, or death) and death using Cox regression. All models evaluating AP included PP to assess whether AP adds to the information already provided by PP. Both AP and AIx significantly predicted MACE. The hazard ratio (HR) per 10 mm Hg increase in AP was 1.20 (95% confidence interval [CI], 1.08 to 1.34; P < 0.001); the HR for each 10% increase in AIx was 1.28 (95% CI, 1.11 to 1.48; P = 0.004). After adjusting for other univariate predictors of MACE, age, and other potential confounders, AP remained a significant predictor of MACE (HR per 10 mm Hg increase = 1.19; 95% CI, 1.06 to 1.34; P = 0.002), as did AIx (adjusted HR, 1.28; 95% CI, 1.09 to 1.50; P = 0.003). AP was a significant predictor of death (HR per 10 mm Hg increase = 1.18; 95% CI, 1.02 to 1.39; P = 0.03). Higher AIx was associated with a trend toward increased mortality (HR = 1.22; 95% CI, 0.98 to 1.52; P = 0.056). Aortic AP predicts adverse outcomes in patients with CAD independently of PP and other risk markers.

Original languageEnglish
Pages (from-to)980-985
Number of pages6
JournalHypertension
Volume45
Issue number5
DOIs
StatePublished - May 1 2005

Fingerprint

Coronary Artery Disease
Arterial Pressure
Pressure
Confidence Intervals
Blood Pressure
Vascular Stiffness
Unstable Angina
Coronary Angiography
Catheterization
Stroke
Myocardial Infarction
Mortality

Keywords

  • Arterial stiffness
  • Cardiovascular events
  • Coronary angiography
  • Coronary artery disease
  • Prospective study

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. / Chirinos, Julio A.; Zambrano, Juan P.; Chakko, Simon; Veerani, Anila; Schob, Alan; Willens, Howard J.; Perez, Guido; Mendez, Armando J.

In: Hypertension, Vol. 45, No. 5, 01.05.2005, p. 980-985.

Research output: Contribution to journalArticle

Chirinos, Julio A. ; Zambrano, Juan P. ; Chakko, Simon ; Veerani, Anila ; Schob, Alan ; Willens, Howard J. ; Perez, Guido ; Mendez, Armando J. / Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease. In: Hypertension. 2005 ; Vol. 45, No. 5. pp. 980-985.
@article{acfc91ad092541cf9cb4e17bab799ff6,
title = "Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease",
abstract = "Pulse pressure (PP), a marker of arterial stiffness, predicts cardiovascular risk. We aimed to determine whether augmentation pressure (AP) derived from the aortic pressure waveform predicts major adverse cardiovascular events (MACE) and death independently of PP in patients with established coronary artery disease (CAD). We prospectively followed-up 297 males undergoing coronary angiography for 1186 ± 424 days. Ascending aortic pressure tracings obtained during catheterization were used to calculate AP (difference between the second and the first systolic peak). Augmentation index (AIx) was defined as AP as a percentage of PP. We evaluated whether AP and AIx can predict the risk of MACE (unstable angina, acute myocardial infarction, coronary revascularization, stroke, or death) and death using Cox regression. All models evaluating AP included PP to assess whether AP adds to the information already provided by PP. Both AP and AIx significantly predicted MACE. The hazard ratio (HR) per 10 mm Hg increase in AP was 1.20 (95{\%} confidence interval [CI], 1.08 to 1.34; P < 0.001); the HR for each 10{\%} increase in AIx was 1.28 (95{\%} CI, 1.11 to 1.48; P = 0.004). After adjusting for other univariate predictors of MACE, age, and other potential confounders, AP remained a significant predictor of MACE (HR per 10 mm Hg increase = 1.19; 95{\%} CI, 1.06 to 1.34; P = 0.002), as did AIx (adjusted HR, 1.28; 95{\%} CI, 1.09 to 1.50; P = 0.003). AP was a significant predictor of death (HR per 10 mm Hg increase = 1.18; 95{\%} CI, 1.02 to 1.39; P = 0.03). Higher AIx was associated with a trend toward increased mortality (HR = 1.22; 95{\%} CI, 0.98 to 1.52; P = 0.056). Aortic AP predicts adverse outcomes in patients with CAD independently of PP and other risk markers.",
keywords = "Arterial stiffness, Cardiovascular events, Coronary angiography, Coronary artery disease, Prospective study",
author = "Chirinos, {Julio A.} and Zambrano, {Juan P.} and Simon Chakko and Anila Veerani and Alan Schob and Willens, {Howard J.} and Guido Perez and Mendez, {Armando J}",
year = "2005",
month = "5",
day = "1",
doi = "10.1161/01.HYP.0000165025.16381.44",
language = "English",
volume = "45",
pages = "980--985",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Aortic pressure augmentation predicts adverse cardiovascular events in patients with established coronary artery disease

AU - Chirinos, Julio A.

AU - Zambrano, Juan P.

AU - Chakko, Simon

AU - Veerani, Anila

AU - Schob, Alan

AU - Willens, Howard J.

AU - Perez, Guido

AU - Mendez, Armando J

PY - 2005/5/1

Y1 - 2005/5/1

N2 - Pulse pressure (PP), a marker of arterial stiffness, predicts cardiovascular risk. We aimed to determine whether augmentation pressure (AP) derived from the aortic pressure waveform predicts major adverse cardiovascular events (MACE) and death independently of PP in patients with established coronary artery disease (CAD). We prospectively followed-up 297 males undergoing coronary angiography for 1186 ± 424 days. Ascending aortic pressure tracings obtained during catheterization were used to calculate AP (difference between the second and the first systolic peak). Augmentation index (AIx) was defined as AP as a percentage of PP. We evaluated whether AP and AIx can predict the risk of MACE (unstable angina, acute myocardial infarction, coronary revascularization, stroke, or death) and death using Cox regression. All models evaluating AP included PP to assess whether AP adds to the information already provided by PP. Both AP and AIx significantly predicted MACE. The hazard ratio (HR) per 10 mm Hg increase in AP was 1.20 (95% confidence interval [CI], 1.08 to 1.34; P < 0.001); the HR for each 10% increase in AIx was 1.28 (95% CI, 1.11 to 1.48; P = 0.004). After adjusting for other univariate predictors of MACE, age, and other potential confounders, AP remained a significant predictor of MACE (HR per 10 mm Hg increase = 1.19; 95% CI, 1.06 to 1.34; P = 0.002), as did AIx (adjusted HR, 1.28; 95% CI, 1.09 to 1.50; P = 0.003). AP was a significant predictor of death (HR per 10 mm Hg increase = 1.18; 95% CI, 1.02 to 1.39; P = 0.03). Higher AIx was associated with a trend toward increased mortality (HR = 1.22; 95% CI, 0.98 to 1.52; P = 0.056). Aortic AP predicts adverse outcomes in patients with CAD independently of PP and other risk markers.

AB - Pulse pressure (PP), a marker of arterial stiffness, predicts cardiovascular risk. We aimed to determine whether augmentation pressure (AP) derived from the aortic pressure waveform predicts major adverse cardiovascular events (MACE) and death independently of PP in patients with established coronary artery disease (CAD). We prospectively followed-up 297 males undergoing coronary angiography for 1186 ± 424 days. Ascending aortic pressure tracings obtained during catheterization were used to calculate AP (difference between the second and the first systolic peak). Augmentation index (AIx) was defined as AP as a percentage of PP. We evaluated whether AP and AIx can predict the risk of MACE (unstable angina, acute myocardial infarction, coronary revascularization, stroke, or death) and death using Cox regression. All models evaluating AP included PP to assess whether AP adds to the information already provided by PP. Both AP and AIx significantly predicted MACE. The hazard ratio (HR) per 10 mm Hg increase in AP was 1.20 (95% confidence interval [CI], 1.08 to 1.34; P < 0.001); the HR for each 10% increase in AIx was 1.28 (95% CI, 1.11 to 1.48; P = 0.004). After adjusting for other univariate predictors of MACE, age, and other potential confounders, AP remained a significant predictor of MACE (HR per 10 mm Hg increase = 1.19; 95% CI, 1.06 to 1.34; P = 0.002), as did AIx (adjusted HR, 1.28; 95% CI, 1.09 to 1.50; P = 0.003). AP was a significant predictor of death (HR per 10 mm Hg increase = 1.18; 95% CI, 1.02 to 1.39; P = 0.03). Higher AIx was associated with a trend toward increased mortality (HR = 1.22; 95% CI, 0.98 to 1.52; P = 0.056). Aortic AP predicts adverse outcomes in patients with CAD independently of PP and other risk markers.

KW - Arterial stiffness

KW - Cardiovascular events

KW - Coronary angiography

KW - Coronary artery disease

KW - Prospective study

UR - http://www.scopus.com/inward/record.url?scp=18244384960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244384960&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000165025.16381.44

DO - 10.1161/01.HYP.0000165025.16381.44

M3 - Article

C2 - 15837821

AN - SCOPUS:18244384960

VL - 45

SP - 980

EP - 985

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 5

ER -